| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $67.4M | — |
| R&D Expense | $167.8M | -11.5% |
| SG&A Expense | $87.1M | +35.4% |
| Operating Income | -$191.2M | +36.2% |
| Pre-tax Income | -$165.7M | +43.4% |
| Income Tax | $177K | +129.5% |
| Net Income | -$165.8M | +43.2% |
| EPS (Basic) | -$2.33 | +47.9% |
| EPS (Diluted) | -$2.33 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.9M | +20.9% |
| Accounts Receivable | $5.0M | — |
| Current Assets | $386.1M | -22.3% |
| Total Assets | $430.3M | -22.0% |
| Current Liabilities | $52.7M | -24.0% |
| Total Liabilities | $93.2M | -18.5% |
| Stockholders' Equity | $337.2M | -22.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$170.9M | +17.8% |
| Capital Expenditures | $221K | -62.1% |
| Investing Cash Flow | $176.6M | +497.1% |
| Financing Cash Flow | $108K | -100.0% |
| Free Cash Flow | -$171.1M | +17.9% |
| +47.9% |